Advertisement
In his new role, Mr. Barnes will lead the P\S\L Research Group, whichconsists of all existing research businesses: P\S\L Research International,P\S\L Research Europe and P\S\L Research Canada. His focus will be to ensurethat the existing research businesses continue to realize their fullpotential, and also to develop new research and consulting services to supportspecific market-focused client needs.
Advertisement
"With the creation of Business Groups, P\S\L is providing a framework forcontinued growth of the network of research, medical information and educationbusinesses," states Michele Fearon, CEO P\S\L Group. "This structure willcreate an executive management team for each major business field andestablish the environment and infrastructure to encourage the emergence ofseveral new business units, each focused on leveraging P\S\L Group assets. Weare delighted to welcome Paul to the organization."
Mr. Barnes brings 20 years of global market research experience in thepharmaceutical industry. He has spent the past 12 years at TNS, one of thelargest healthcare market research agencies worldwide, where most recently hewas president for TNS' US healthcare unit. Earlier in his career he worked insales and marketing on the client side with Glaxo and Lederle.
"P\S\L Group has a strong and unique combination of research andinformation assets to support pharmaceutical clients," commented Mr. Barnes."I am very excited about joining such a dynamic organization and look forwardto working with the very talented team in the P\S\L Research Group."
Mr. Barnes will be based in the P\S\L US head office located at 24 W. 40thStreet, Suite 800, New York, NY, 10018.
About P\S\L Group
P\S\L Group is a global organization dedicated to putting information atthe service of medicine. The companies and people of the P\S\L Group aim toimprove medical care by serving those who need it, those who provide it andthose who seek to improve it.
P\S\L Group business purpose and strategic intent
P\S\L Group clients include research-based pharmaceutical companies andother healthcare institutions who seek the advancement of medicine. Ourprimary business purpose is to help these clients increase the effectiveness,as well as lower the cost, of activities pertaining to scientificcommunication, medical education or product/service marketing.
SOURCE P\S\L Group
